Legal and regulatory experts expect litigation to arise if the FDA seeks to enforce its pharma DTC ad crackdown, though how it might play out is nuanced.
The FDA asserted that the 90-second TV ad misbrands Novartis’ Fabhalta and makes the distribution of the drug in violation of the Federal Food, Drug, and Cosmetic Act.
BMS to sell psoriasis drug at 80% discount through new DTC platform; Dr. Mehmet Oz breaks with Trump on Tylenol use; U.K.
More and more patients are turning to AI for therapy, but the space is becoming littered with negative outcomes. Can marketers change this trajectory?
Clinical teams across the country are forming a five-year, $37 million consortium to research stillbirth, a long-neglected public health concern. “There’s no question that the ProPublica reporting was ...
The hospital said the price for Deborah Buttgereit’s surgery increased because doctors encountered complications midprocedure.
Republican lawmakers cite Georgia’s Pathways to Coverage as a national model for federal Medicaid work requirements that are set to take effect in 2027. A new report shows the program has spent at ...
Kantar’s Media Reactions report places Amazon, Twitch and Prime Video in three out of the top five consumers’ preferred ad spaces.
How to move beyond rigid planning to embrace agility, foresight and collaboration that drives real launch success.
Women’s health supplements brand O Positiv created a 12-foot-tall vagina and placed it in New York City’s Gansevoort Plaza. O ...
Taking a page from the private insurance industry’s playbook, the Trump administration will launch a program next year to find out how much money an artificial intelligence algorithm could save the ...
Taking a page from the private insurance industry’s playbook, the Trump administration will launch a program next year to find out how much money an artificial intelligence algorithm could save the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results